AHMEDABAD, India, July 22, 2021 /PRNewswire/ --Intas Pharmaceuticals ... Meiji is a leading pharmaceutical company in Japan in the therapeutic ...
Read more: Intas Enters into an Exclusive License Agreement with Meiji and Dong-A ST to commercialize DMB ...